Global Merkel Cell Carcinoma Treatment Market Research Report 2023

Merkel Cell Carcinoma, a skin malignancy, is caused by the uncontrolled development of Merkel cells in the skin. MCC was originally first described by Toker in 1972. The malady is to a great extent caused by Merkel Cell Polyomavirus (MCV) on parts of the skin in the head, neck and arms, generally occurs most often on sun-exposed areas of the skin. 

The global Merkel Cell Carcinoma Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Merkel Cell Carcinoma Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Merkel Cell Carcinoma Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Merkel Cell Carcinoma Treatment in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Merkel Cell Carcinoma Treatment include Merck, Amgen Inc, Apcure SAS, BeiGene Ltd, Immune Design Corp, Millennium Pharmaceuticals Inc, NantKwest Inc, Novartis AG and OncoSec Medical Inc, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Merkel Cell Carcinoma Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Merkel Cell Carcinoma Treatment.

The Merkel Cell Carcinoma Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Merkel Cell Carcinoma Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Merkel Cell Carcinoma Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Merkel Cell Carcinoma Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Chemotherapy

1.2.3 Immunotherapy

1.2.4 Combination Therapies

1.3 Market by Application

1.3.1 Global Merkel Cell Carcinoma Treatment Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centres

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Merkel Cell Carcinoma Treatment Market Perspective (2018-2029)

2.2 Merkel Cell Carcinoma Treatment Growth Trends by Region

2.2.1 Global Merkel Cell Carcinoma Treatment Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Merkel Cell Carcinoma Treatment Historic Market Size by Region (2018-2023)

2.2.3 Merkel Cell Carcinoma Treatment Forecasted Market Size by Region (2024-2029)

2.3 Merkel Cell Carcinoma Treatment Market Dynamics

2.3.1 Merkel Cell Carcinoma Treatment Industry Trends

2.3.2 Merkel Cell Carcinoma Treatment Market Drivers

2.3.3 Merkel Cell Carcinoma Treatment Market Challenges

2.3.4 Merkel Cell Carcinoma Treatment Market Restraints

3.1 Global Top Merkel Cell Carcinoma Treatment Players by Revenue

3.1.1 Global Top Merkel Cell Carcinoma Treatment Players by Revenue (2018-2023)

3.1.2 Global Merkel Cell Carcinoma Treatment Revenue Market Share by Players (2018-2023)

3.2 Global Merkel Cell Carcinoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Merkel Cell Carcinoma Treatment Revenue

3.4 Global Merkel Cell Carcinoma Treatment Market Concentration Ratio

3.4.1 Global Merkel Cell Carcinoma Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Merkel Cell Carcinoma Treatment Revenue in 2022

3.5 Merkel Cell Carcinoma Treatment Key Players Head office and Area Served

3.6 Key Players Merkel Cell Carcinoma Treatment Product Solution and Service

3.7 Date of Enter into Merkel Cell Carcinoma Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Merkel Cell Carcinoma Treatment Historic Market Size by Type (2018-2023)

4.2 Global Merkel Cell Carcinoma Treatment Forecasted Market Size by Type (2024-2029)

5.1 Global Merkel Cell Carcinoma Treatment Historic Market Size by Application (2018-2023)

5.2 Global Merkel Cell Carcinoma Treatment Forecasted Market Size by Application (2024-2029)

6.1 North America Merkel Cell Carcinoma Treatment Market Size (2018-2029)

6.2 North America Merkel Cell Carcinoma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Merkel Cell Carcinoma Treatment Market Size by Country (2018-2023)

6.4 North America Merkel Cell Carcinoma Treatment Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Merkel Cell Carcinoma Treatment Market Size (2018-2029)

7.2 Europe Merkel Cell Carcinoma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Merkel Cell Carcinoma Treatment Market Size by Country (2018-2023)

7.4 Europe Merkel Cell Carcinoma Treatment Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Merkel Cell Carcinoma Treatment Market Size (2018-2029)

8.2 Asia-Pacific Merkel Cell Carcinoma Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Merkel Cell Carcinoma Treatment Market Size by Region (2018-2023)

8.4 Asia-Pacific Merkel Cell Carcinoma Treatment Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Merkel Cell Carcinoma Treatment Market Size (2018-2029)

9.2 Latin America Merkel Cell Carcinoma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Merkel Cell Carcinoma Treatment Market Size by Country (2018-2023)

9.4 Latin America Merkel Cell Carcinoma Treatment Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Merkel Cell Carcinoma Treatment Market Size (2018-2029)

10.2 Middle East & Africa Merkel Cell Carcinoma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Merkel Cell Carcinoma Treatment Market Size by Country (2018-2023)

10.4 Middle East & Africa Merkel Cell Carcinoma Treatment Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Merck

11.1.1 Merck Company Detail

11.1.2 Merck Business Overview

11.1.3 Merck Merkel Cell Carcinoma Treatment Introduction

11.1.4 Merck Revenue in Merkel Cell Carcinoma Treatment Business (2018-2023)

11.1.5 Merck Recent Development

11.2 Amgen Inc

11.2.1 Amgen Inc Company Detail

11.2.2 Amgen Inc Business Overview

11.2.3 Amgen Inc Merkel Cell Carcinoma Treatment Introduction

11.2.4 Amgen Inc Revenue in Merkel Cell Carcinoma Treatment Business (2018-2023)

11.2.5 Amgen Inc Recent Development

11.3 Apcure SAS

11.3.1 Apcure SAS Company Detail

11.3.2 Apcure SAS Business Overview

11.3.3 Apcure SAS Merkel Cell Carcinoma Treatment Introduction

11.3.4 Apcure SAS Revenue in Merkel Cell Carcinoma Treatment Business (2018-2023)

11.3.5 Apcure SAS Recent Development

11.4 BeiGene Ltd

11.4.1 BeiGene Ltd Company Detail

11.4.2 BeiGene Ltd Business Overview

11.4.3 BeiGene Ltd Merkel Cell Carcinoma Treatment Introduction

11.4.4 BeiGene Ltd Revenue in Merkel Cell Carcinoma Treatment Business (2018-2023)

11.4.5 BeiGene Ltd Recent Development

11.5 Immune Design Corp

11.5.1 Immune Design Corp Company Detail

11.5.2 Immune Design Corp Business Overview

11.5.3 Immune Design Corp Merkel Cell Carcinoma Treatment Introduction

11.5.4 Immune Design Corp Revenue in Merkel Cell Carcinoma Treatment Business (2018-2023)

11.5.5 Immune Design Corp Recent Development

11.6 Millennium Pharmaceuticals Inc

11.6.1 Millennium Pharmaceuticals Inc Company Detail

11.6.2 Millennium Pharmaceuticals Inc Business Overview

11.6.3 Millennium Pharmaceuticals Inc Merkel Cell Carcinoma Treatment Introduction

11.6.4 Millennium Pharmaceuticals Inc Revenue in Merkel Cell Carcinoma Treatment Business (2018-2023)

11.6.5 Millennium Pharmaceuticals Inc Recent Development

11.7 NantKwest Inc

11.7.1 NantKwest Inc Company Detail

11.7.2 NantKwest Inc Business Overview

11.7.3 NantKwest Inc Merkel Cell Carcinoma Treatment Introduction

11.7.4 NantKwest Inc Revenue in Merkel Cell Carcinoma Treatment Business (2018-2023)

11.7.5 NantKwest Inc Recent Development

11.8 Novartis AG

11.8.1 Novartis AG Company Detail

11.8.2 Novartis AG Business Overview

11.8.3 Novartis AG Merkel Cell Carcinoma Treatment Introduction

11.8.4 Novartis AG Revenue in Merkel Cell Carcinoma Treatment Business (2018-2023)

11.8.5 Novartis AG Recent Development

11.9 OncoSec Medical Inc

11.9.1 OncoSec Medical Inc Company Detail

11.9.2 OncoSec Medical Inc Business Overview

11.9.3 OncoSec Medical Inc Merkel Cell Carcinoma Treatment Introduction

11.9.4 OncoSec Medical Inc Revenue in Merkel Cell Carcinoma Treatment Business (2018-2023)

11.9.5 OncoSec Medical Inc Recent Development

11.10 Oncovir Inc

11.10.1 Oncovir Inc Company Detail

11.10.2 Oncovir Inc Business Overview

11.10.3 Oncovir Inc Merkel Cell Carcinoma Treatment Introduction

11.10.4 Oncovir Inc Revenue in Merkel Cell Carcinoma Treatment Business (2018-2023)

11.10.5 Oncovir Inc Recent Development

11.11 Ono Pharmaceutical Co Ltd

11.11.1 Ono Pharmaceutical Co Ltd Company Detail

11.11.2 Ono Pharmaceutical Co Ltd Business Overview

11.11.3 Ono Pharmaceutical Co Ltd Merkel Cell Carcinoma Treatment Introduction

11.11.4 Ono Pharmaceutical Co Ltd Revenue in Merkel Cell Carcinoma Treatment Business (2018-2023)

11.11.5 Ono Pharmaceutical Co Ltd Recent Development

11.12 Shanghai Junshi Biosciences Co.,Ltd

11.12.1 Shanghai Junshi Biosciences Co.,Ltd Company Detail

11.12.2 Shanghai Junshi Biosciences Co.,Ltd Business Overview

11.12.3 Shanghai Junshi Biosciences Co.,Ltd Merkel Cell Carcinoma Treatment Introduction

11.12.4 Shanghai Junshi Biosciences Co.,Ltd Revenue in Merkel Cell Carcinoma Treatment Business (2018-2023)

11.12.5 Shanghai Junshi Biosciences Co.,Ltd Recent Development

11.13 Innovent Biologics

11.13.1 Innovent Biologics Company Detail

11.13.2 Innovent Biologics Business Overview

11.13.3 Innovent Biologics Merkel Cell Carcinoma Treatment Introduction

11.13.4 Innovent Biologics Revenue in Merkel Cell Carcinoma Treatment Business (2018-2023)

11.13.5 Innovent Biologics Recent Development

11.14 Jiangsu Hengrui Medicine Co.,Ltd.

11.14.1 Jiangsu Hengrui Medicine Co.,Ltd. Company Detail

11.14.2 Jiangsu Hengrui Medicine Co.,Ltd. Business Overview

11.14.3 Jiangsu Hengrui Medicine Co.,Ltd. Merkel Cell Carcinoma Treatment Introduction

11.14.4 Jiangsu Hengrui Medicine Co.,Ltd. Revenue in Merkel Cell Carcinoma Treatment Business (2018-2023)

11.14.5 Jiangsu Hengrui Medicine Co.,Ltd. Recent Development

11.15 AstraZeneca

11.15.1 AstraZeneca Company Detail

11.15.2 AstraZeneca Business Overview

11.15.3 AstraZeneca Merkel Cell Carcinoma Treatment Introduction

11.15.4 AstraZeneca Revenue in Merkel Cell Carcinoma Treatment Business (2018-2023)

11.15.5 AstraZeneca Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Merkel Cell Carcinoma Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Chemotherapy

    Table 3. Key Players of Immunotherapy

    Table 4. Key Players of Combination Therapies

    Table 5. Global Merkel Cell Carcinoma Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Merkel Cell Carcinoma Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Merkel Cell Carcinoma Treatment Market Size by Region (2018-2023) & (US$ Million)

    Table 8. Global Merkel Cell Carcinoma Treatment Market Share by Region (2018-2023)

    Table 9. Global Merkel Cell Carcinoma Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 10. Global Merkel Cell Carcinoma Treatment Market Share by Region (2024-2029)

    Table 11. Merkel Cell Carcinoma Treatment Market Trends

    Table 12. Merkel Cell Carcinoma Treatment Market Drivers

    Table 13. Merkel Cell Carcinoma Treatment Market Challenges

    Table 14. Merkel Cell Carcinoma Treatment Market Restraints

    Table 15. Global Merkel Cell Carcinoma Treatment Revenue by Players (2018-2023) & (US$ Million)

    Table 16. Global Merkel Cell Carcinoma Treatment Market Share by Players (2018-2023)

    Table 17. Global Top Merkel Cell Carcinoma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Merkel Cell Carcinoma Treatment as of 2022)

    Table 18. Ranking of Global Top Merkel Cell Carcinoma Treatment Companies by Revenue (US$ Million) in 2022

    Table 19. Global 5 Largest Players Market Share by Merkel Cell Carcinoma Treatment Revenue (CR5 and HHI) & (2018-2023)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Merkel Cell Carcinoma Treatment Product Solution and Service

    Table 22. Date of Enter into Merkel Cell Carcinoma Treatment Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Merkel Cell Carcinoma Treatment Market Size by Type (2018-2023) & (US$ Million)

    Table 25. Global Merkel Cell Carcinoma Treatment Revenue Market Share by Type (2018-2023)

    Table 26. Global Merkel Cell Carcinoma Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 27. Global Merkel Cell Carcinoma Treatment Revenue Market Share by Type (2024-2029)

    Table 28. Global Merkel Cell Carcinoma Treatment Market Size by Application (2018-2023) & (US$ Million)

    Table 29. Global Merkel Cell Carcinoma Treatment Revenue Market Share by Application (2018-2023)

    Table 30. Global Merkel Cell Carcinoma Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 31. Global Merkel Cell Carcinoma Treatment Revenue Market Share by Application (2024-2029)

    Table 32. North America Merkel Cell Carcinoma Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 33. North America Merkel Cell Carcinoma Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 34. North America Merkel Cell Carcinoma Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 35. Europe Merkel Cell Carcinoma Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. Europe Merkel Cell Carcinoma Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 37. Europe Merkel Cell Carcinoma Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Asia-Pacific Merkel Cell Carcinoma Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Asia-Pacific Merkel Cell Carcinoma Treatment Market Size by Region (2018-2023) & (US$ Million)

    Table 40. Asia-Pacific Merkel Cell Carcinoma Treatment Market Size by Region (2024-2029) & (US$ Million)

    Table 41. Latin America Merkel Cell Carcinoma Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Latin America Merkel Cell Carcinoma Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 43. Latin America Merkel Cell Carcinoma Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 44. Middle East & Africa Merkel Cell Carcinoma Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Middle East & Africa Merkel Cell Carcinoma Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Middle East & Africa Merkel Cell Carcinoma Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 47. Merck Company Detail

    Table 48. Merck Business Overview

    Table 49. Merck Merkel Cell Carcinoma Treatment Product

    Table 50. Merck Revenue in Merkel Cell Carcinoma Treatment Business (2018-2023) & (US$ Million)

    Table 51. Merck Recent Development

    Table 52. Amgen Inc Company Detail

    Table 53. Amgen Inc Business Overview

    Table 54. Amgen Inc Merkel Cell Carcinoma Treatment Product

    Table 55. Amgen Inc Revenue in Merkel Cell Carcinoma Treatment Business (2018-2023) & (US$ Million)

    Table 56. Amgen Inc Recent Development

    Table 57. Apcure SAS Company Detail

    Table 58. Apcure SAS Business Overview

    Table 59. Apcure SAS Merkel Cell Carcinoma Treatment Product

    Table 60. Apcure SAS Revenue in Merkel Cell Carcinoma Treatment Business (2018-2023) & (US$ Million)

    Table 61. Apcure SAS Recent Development

    Table 62. BeiGene Ltd Company Detail

    Table 63. BeiGene Ltd Business Overview

    Table 64. BeiGene Ltd Merkel Cell Carcinoma Treatment Product

    Table 65. BeiGene Ltd Revenue in Merkel Cell Carcinoma Treatment Business (2018-2023) & (US$ Million)

    Table 66. BeiGene Ltd Recent Development

    Table 67. Immune Design Corp Company Detail

    Table 68. Immune Design Corp Business Overview

    Table 69. Immune Design Corp Merkel Cell Carcinoma Treatment Product

    Table 70. Immune Design Corp Revenue in Merkel Cell Carcinoma Treatment Business (2018-2023) & (US$ Million)

    Table 71. Immune Design Corp Recent Development

    Table 72. Millennium Pharmaceuticals Inc Company Detail

    Table 73. Millennium Pharmaceuticals Inc Business Overview

    Table 74. Millennium Pharmaceuticals Inc Merkel Cell Carcinoma Treatment Product

    Table 75. Millennium Pharmaceuticals Inc Revenue in Merkel Cell Carcinoma Treatment Business (2018-2023) & (US$ Million)

    Table 76. Millennium Pharmaceuticals Inc Recent Development

    Table 77. NantKwest Inc Company Detail

    Table 78. NantKwest Inc Business Overview

    Table 79. NantKwest Inc Merkel Cell Carcinoma Treatment Product

    Table 80. NantKwest Inc Revenue in Merkel Cell Carcinoma Treatment Business (2018-2023) & (US$ Million)

    Table 81. NantKwest Inc Recent Development

    Table 82. Novartis AG Company Detail

    Table 83. Novartis AG Business Overview

    Table 84. Novartis AG Merkel Cell Carcinoma Treatment Product

    Table 85. Novartis AG Revenue in Merkel Cell Carcinoma Treatment Business (2018-2023) & (US$ Million)

    Table 86. Novartis AG Recent Development

    Table 87. OncoSec Medical Inc Company Detail

    Table 88. OncoSec Medical Inc Business Overview

    Table 89. OncoSec Medical Inc Merkel Cell Carcinoma Treatment Product

    Table 90. OncoSec Medical Inc Revenue in Merkel Cell Carcinoma Treatment Business (2018-2023) & (US$ Million)

    Table 91. OncoSec Medical Inc Recent Development

    Table 92. Oncovir Inc Company Detail

    Table 93. Oncovir Inc Business Overview

    Table 94. Oncovir Inc Merkel Cell Carcinoma Treatment Product

    Table 95. Oncovir Inc Revenue in Merkel Cell Carcinoma Treatment Business (2018-2023) & (US$ Million)

    Table 96. Oncovir Inc Recent Development

    Table 97. Ono Pharmaceutical Co Ltd Company Detail

    Table 98. Ono Pharmaceutical Co Ltd Business Overview

    Table 99. Ono Pharmaceutical Co Ltd Merkel Cell Carcinoma Treatment Product

    Table 100. Ono Pharmaceutical Co Ltd Revenue in Merkel Cell Carcinoma Treatment Business (2018-2023) & (US$ Million)

    Table 101. Ono Pharmaceutical Co Ltd Recent Development

    Table 102. Shanghai Junshi Biosciences Co.,Ltd Company Detail

    Table 103. Shanghai Junshi Biosciences Co.,Ltd Business Overview

    Table 104. Shanghai Junshi Biosciences Co.,Ltd Merkel Cell Carcinoma Treatment Product

    Table 105. Shanghai Junshi Biosciences Co.,Ltd Revenue in Merkel Cell Carcinoma Treatment Business (2018-2023) & (US$ Million)

    Table 106. Shanghai Junshi Biosciences Co.,Ltd Recent Development

    Table 107. Innovent Biologics Company Detail

    Table 108. Innovent Biologics Business Overview

    Table 109. Innovent Biologics Merkel Cell Carcinoma Treatment Product

    Table 110. Innovent Biologics Revenue in Merkel Cell Carcinoma Treatment Business (2018-2023) & (US$ Million)

    Table 111. Innovent Biologics Recent Development

    Table 112. Jiangsu Hengrui Medicine Co.,Ltd. Company Detail

    Table 113. Jiangsu Hengrui Medicine Co.,Ltd. Business Overview

    Table 114. Jiangsu Hengrui Medicine Co.,Ltd. Merkel Cell Carcinoma Treatment Product

    Table 115. Jiangsu Hengrui Medicine Co.,Ltd. Revenue in Merkel Cell Carcinoma Treatment Business (2018-2023) & (US$ Million)

    Table 116. Jiangsu Hengrui Medicine Co.,Ltd. Recent Development

    Table 117. AstraZeneca Company Detail

    Table 118. AstraZeneca Business Overview

    Table 119. AstraZeneca Merkel Cell Carcinoma Treatment Product

    Table 120. AstraZeneca Revenue in Merkel Cell Carcinoma Treatment Business (2018-2023) & (US$ Million)

    Table 121. AstraZeneca Recent Development

    Table 122. Research Programs/Design for This Report

    Table 123. Key Data Information from Secondary Sources

    Table 124. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Merkel Cell Carcinoma Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Merkel Cell Carcinoma Treatment Market Share by Type: 2022 VS 2029

    Figure 3. Chemotherapy Features

    Figure 4. Immunotherapy Features

    Figure 5. Combination Therapies Features

    Figure 6. Global Merkel Cell Carcinoma Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Merkel Cell Carcinoma Treatment Market Share by Application: 2022 VS 2029

    Figure 8. Hospitals Case Studies

    Figure 9. Ambulatory Surgical Centres Case Studies

    Figure 10. Others Case Studies

    Figure 11. Merkel Cell Carcinoma Treatment Report Years Considered

    Figure 12. Global Merkel Cell Carcinoma Treatment Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 13. Global Merkel Cell Carcinoma Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 14. Global Merkel Cell Carcinoma Treatment Market Share by Region: 2022 VS 2029

    Figure 15. Global Merkel Cell Carcinoma Treatment Market Share by Players in 2022

    Figure 16. Global Top Merkel Cell Carcinoma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Merkel Cell Carcinoma Treatment as of 2022)

    Figure 17. The Top 10 and 5 Players Market Share by Merkel Cell Carcinoma Treatment Revenue in 2022

    Figure 18. North America Merkel Cell Carcinoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 19. North America Merkel Cell Carcinoma Treatment Market Share by Country (2018-2029)

    Figure 20. United States Merkel Cell Carcinoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Canada Merkel Cell Carcinoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Merkel Cell Carcinoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Merkel Cell Carcinoma Treatment Market Share by Country (2018-2029)

    Figure 24. Germany Merkel Cell Carcinoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. France Merkel Cell Carcinoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. U.K. Merkel Cell Carcinoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Italy Merkel Cell Carcinoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Russia Merkel Cell Carcinoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Nordic Countries Merkel Cell Carcinoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Merkel Cell Carcinoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Merkel Cell Carcinoma Treatment Market Share by Region (2018-2029)

    Figure 32. China Merkel Cell Carcinoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Japan Merkel Cell Carcinoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. South Korea Merkel Cell Carcinoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Southeast Asia Merkel Cell Carcinoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. India Merkel Cell Carcinoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Australia Merkel Cell Carcinoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Merkel Cell Carcinoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Merkel Cell Carcinoma Treatment Market Share by Country (2018-2029)

    Figure 40. Mexico Merkel Cell Carcinoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Brazil Merkel Cell Carcinoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Merkel Cell Carcinoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Merkel Cell Carcinoma Treatment Market Share by Country (2018-2029)

    Figure 44. Turkey Merkel Cell Carcinoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Saudi Arabia Merkel Cell Carcinoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Merck Revenue Growth Rate in Merkel Cell Carcinoma Treatment Business (2018-2023)

    Figure 47. Amgen Inc Revenue Growth Rate in Merkel Cell Carcinoma Treatment Business (2018-2023)

    Figure 48. Apcure SAS Revenue Growth Rate in Merkel Cell Carcinoma Treatment Business (2018-2023)

    Figure 49. BeiGene Ltd Revenue Growth Rate in Merkel Cell Carcinoma Treatment Business (2018-2023)

    Figure 50. Immune Design Corp Revenue Growth Rate in Merkel Cell Carcinoma Treatment Business (2018-2023)

    Figure 51. Millennium Pharmaceuticals Inc Revenue Growth Rate in Merkel Cell Carcinoma Treatment Business (2018-2023)

    Figure 52. NantKwest Inc Revenue Growth Rate in Merkel Cell Carcinoma Treatment Business (2018-2023)

    Figure 53. Novartis AG Revenue Growth Rate in Merkel Cell Carcinoma Treatment Business (2018-2023)

    Figure 54. OncoSec Medical Inc Revenue Growth Rate in Merkel Cell Carcinoma Treatment Business (2018-2023)

    Figure 55. Oncovir Inc Revenue Growth Rate in Merkel Cell Carcinoma Treatment Business (2018-2023)

    Figure 56. Ono Pharmaceutical Co Ltd Revenue Growth Rate in Merkel Cell Carcinoma Treatment Business (2018-2023)

    Figure 57. Shanghai Junshi Biosciences Co.,Ltd Revenue Growth Rate in Merkel Cell Carcinoma Treatment Business (2018-2023)

    Figure 58. Innovent Biologics Revenue Growth Rate in Merkel Cell Carcinoma Treatment Business (2018-2023)

    Figure 59. Jiangsu Hengrui Medicine Co.,Ltd. Revenue Growth Rate in Merkel Cell Carcinoma Treatment Business (2018-2023)

    Figure 60. AstraZeneca Revenue Growth Rate in Merkel Cell Carcinoma Treatment Business (2018-2023)

    Figure 61. Bottom-up and Top-down Approaches for This Report

    Figure 62. Data Triangulation

    Figure 63. Key Executives Interviewed